Moderna's cancer breakthrough, two new holdings in EQT and Vistra tackling AI's power bottleneck, Nubank's founder joins the OpenAI boards, and why we've sold Delivery Hero after nine years. Capital at risk.
Read more >
Moderna's cancer breakthrough, two new holdings in EQT and Vistra tackling AI's power bottleneck, Nubank's founder joins the OpenAI boards, and why we've sold Delivery Hero after nine years. Capital at risk.
Baillie Gifford
05 October 2026
Baillie Gifford
02 October 2026
Baillie Gifford
01 October 2026
Baillie Gifford
29 September 2026
Baillie Gifford
29 September 2026
Loading...